Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
TELO
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +22.9%
TELO
Telomir Pharmaceuticals, Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
telomir
nasdaq
market
pharmaceuticals
clinical
trading
after
reported
related
data
results
stocks
today
2024
caps
around
applovin
development
telomere
study
StonvexStonvexStonvexStonvex